These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. Socio-behavioral dysfunction in disorders of hypothalamic-pituitary involvement: The potential role of disease-induced oxytocin and vasopressin signaling deficits. Clarke L; Zyga O; Pineo-Cavanaugh PL; Jeng M; Fischbein NJ; Partap S; Katznelson L; Parker KJ Neurosci Biobehav Rev; 2022 Sep; 140():104770. PubMed ID: 35803395 [TBL] [Abstract][Full Text] [Related]
84. [Status of vasopressin-, oxytocin- and corticoliberin-synthesizing structures of the hypothalamus in experimental diabetes mellitus in rats of different sexes]. Kolesnik IuM; Orestenko IuN; Abramov AV Probl Endokrinol (Mosk); 1993; 39(1):45-8. PubMed ID: 8058664 [TBL] [Abstract][Full Text] [Related]
85. [Contribution of immunocytochemistry to the study of the development of neuroglandular peptidergic systems in the human fetal hypothalamus]. Bugnon C; Fellmann D; Bloch B; Bresson JL; Gouget A; Lenys D; Clavequin MC Ann Endocrinol (Paris); 1987; 48(5):343-51. PubMed ID: 2893577 [TBL] [Abstract][Full Text] [Related]
86. [Current findings in the regulation of formation of corticoliberin, pro-opiomelanocortin and ACTH as well as the efficacy of these compounds]. Kolb E Z Gesamte Inn Med; 1990 Jul; 45(14):397-402. PubMed ID: 1963505 [TBL] [Abstract][Full Text] [Related]
87. Oxytocin and vasopressin. From genes to peptides. Gainer H; Wray S Ann N Y Acad Sci; 1992 Jun; 652():14-28. PubMed ID: 1626825 [No Abstract] [Full Text] [Related]